comparemela.com

Latest Breaking News On - Aficamten - Page 1 : comparemela.com

Is Exercise Easier for Patients With Hypertrophic Cardiomyopathy With This New Drug?

Is Exercise Easier for Patients With Hypertrophic Cardiomyopathy With This New Drug?
medindia.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medindia.net Daily Mail and Mail on Sunday newspapers.

Aficamten
Symptomatic-obstructive-hypertrophic
Did-you
Hypertrophic-cardiomyopathy
Treatment-options
New-hope
Study-insights
Exercise-capacity

Using Cardiac Myosin Inhibitors for the Treatment of oHCM

Dr James L. Januzzi reviews the use of cardiac myosin inhibitors for the management of oHCM.

Jamesl-januzzi
Cardiac-myosin-inhibitors
Treatment-of-ohcm
Obstructive-hypertrophic-cardiomyopathy
Mavacamten
Aficamten

Clinical Trial Outcomes for Cardiac Myosin Inhibitors in oHCM Treatment

An expert in cardiology shares clinical trial findings of emerging and approved cardiac myosin inhibitors for the treatment of oHCM.

Jamesl-januzzi
Clinical-trial-outcomes
Cardiac-myosin-inhibitors
Ohcm-treatment
Obstructive-hypertrophic-cardiomyopathy
Peak-v02
Safety
Rejection-fraction
Good-monitoring
Explorer-hcm
Valor-hcm

Ahmad Masri, MD, MS: 2024 Update on Development and Future of Cardiac Myosin Inhibitor Class

Ahmad Masri, MD, MS, provides an update on the the development of the cardiac myosin inhibitor class and offers perspective on what the future might hold for the class beyond cardiomyopathy.

Oregon
United-states
Canada
Canadian
Campbellp-cytokinetics
Ahmad-masri
Bristol-myers-squibb
Knight-cardiovascular-institute-at-oregon-health
Pfizer
Astrazeneca
York-heart-association
Drug-administration-approves-camzyos

Cardiology Month in Review: December 2023

Our cardiology month in review spotlights our most popular cardiology-centric content from the month of December 2023. The list includes topline data from SEQUOIA-HCM, new data on the impact of structural racism on chronic health conditions, and more!

United-states
American
American-heart-association
Cytokinetics-inc
Top-news
Diabetes-care
Duke-university-led
Durham-neighborhood-compass
Cardiology
Aficamten
Cardiology-news

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.